PharmaEssentia Corporation is a rapidly growing biopharmaceutical innovator focused on delivering effective new biologics for challenging diseases in hematology and oncology. The company leverages deep expertise and proven scientific principles to develop treatments for patients with limited options, combining rigorous research with innovative thinking. Founded in 2003 by Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, PharmaEssentia has one approved product, BESREMi®, and maintains a diversifying pipeline. The company is listed on the Taiwan Stock Exchange and operates globally with offices in the U.S., Japan, Singapore, South Korea, and China, along with a world-class biologics production facility in Taichung.
Industry
Biopharmaceutical
Company Size
501-1000 employees
Founded
2003
Beta · Sourced from candidate reports
Be the first to share your experience with PharmaEssentia U.S.A..
Your reply helps other candidates know what to expect.
